From the Congressional Budget Office (CBO), July 18, 2025. CBO was asked to assess the effects of a permanent 10 percent reduction in NIH funding and a nine-month increase in FDA review times of new drug applications. SUMMARY STATEMENT: “CBO provides information about how changes to funding for the National…
Updated: